蛋白质稳态
重编程
未折叠蛋白反应
内质网
细胞生物学
肺纤维化
生物
细胞
纤维化
癌症研究
免疫学
病理
医学
遗传学
作者
Jeremy Katzen,L. Raposo Rodríguez,Yaniv Tomer,Apoorva Babu,Ming Zhao,Aditi Murthy,Paige Carson,Matthew Barrett,Maria C. Basil,Justine Carl,John P. Leach,Michael Morley,Matthew McGraw,Surafel Mulugeta,Timothy J. Pelura,Glenn D. Rosen,Edward E. Morrisey,Michael F. Beers
标识
DOI:10.1073/pnas.2123187119
摘要
Disruption of alveolar type 2 cell (AEC2) protein quality control has been implicated in chronic lung diseases, including pulmonary fibrosis (PF). We previously reported the in vivo modeling of a clinical surfactant protein C (SP-C) mutation that led to AEC2 endoplasmic reticulum (ER) stress and spontaneous lung fibrosis, providing proof of concept for disruption to proteostasis as a proximal driver of PF. Using two clinical SP-C mutation models, we have now discovered that AEC2s experiencing significant ER stress lose quintessential AEC2 features and develop a reprogrammed cell state that heretofore has been seen only as a response to lung injury. Using single-cell RNA sequencing in vivo and organoid-based modeling, we show that this state arises de novo from intrinsic AEC2 dysfunction. The cell-autonomous AEC2 reprogramming can be attenuated through inhibition of inositol-requiring enzyme 1 (IRE1α) signaling as the use of an IRE1α inhibitor reduced the development of the reprogrammed cell state and also diminished AEC2-driven recruitment of granulocytes, alveolitis, and lung injury. These findings identify AEC2 proteostasis, and specifically IRE1α signaling through its major product XBP-1, as a driver of a key AEC2 phenotypic change that has been identified in lung fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI